Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Bioinvent, Bristol Myers Squibb, Daiichi Sankyo, Innate, Merck & Co., Recce, Seagen.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Antengene, Apnimed, Cybin, Cymabay, Entrada, Gilgamesh, Lipella, Moleculin, Newamsterdam, Protara, Revolo, Sellas, Travere.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affamed, Alzecure, Asieris, Humanetics, Immpact, Peptilogics, Photocure, Protara, Regulus, Relmada, Seelos, Syndevrx, Vir.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Asieris, Caliway, Foresee, Hutchmed, Innocare, J Ints, Sinovac,Takeda, Urovant.